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Genetic analysis of sudden cardiac death victims: A survey of current 
forensic autopsy practices 
Abstract 
Autopsy negative sudden cardiac deaths (SCD) seen in forensic practice are most often 
thought to be the result of sudden arrhythmic death syndrome. Post-mortem genetic analysis 
is recommended in such cases, but is currently performed in only a few academic centres. 
In order to determine actual current practice, an on-line questionnaire was sent by e-mail to 
members of various forensic medical associations. The questions addressed routine 
procedures employed in cases of sudden cardiac death (autopsy ordering, macroscopic and 
microscopic cardiac examination, conduction tissue examination, immunohistochemistry and 
electron microscopy, biochemical markers, sampling and storage of material for genetic 
analyses, toxicological analyses, and molecular autopsy). Some questions concerned the legal 
and ethical aspects of genetic analyses in post-mortem examinations, as well as any existing 
multidisciplinary collaborations in SCD cases. 
There were 97 respondents, mostly from European countries. Genetic testing in cases of 
sudden cardiac death is rarely practiced in routine forensic investigation. Approximately 60 % 
of respondents reported not having the means to perform genetic post mortem testing and 40 
% do not collect adequate material to perform these investigations at a later date, despite 
working at university hospitals. 
 The survey demonstrated that many of the problems involved in the adequate investigation of 
SCD cases are often financial in origin, due to the fact that activities in forensic medicine are 
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often paid by and dependent on the judicial authorities. Problems also exist concerning the 
contact with family members and/or the family doctor, as well as the often-nonexistent 
collaboration with others clinicians with special expertise beneficial in the investigation of 
SCD cases, such as cardiologists and geneticists.  
This study highlights the importance in establishing guidelines for molecular autopsies in 
forensic medicine. 
Introduction 
The recommendations for the forensic investigation of sudden cardiac deaths (SCD) are 
numerous, addressing both the autopsy and complementary analyses [1,2]. In cases of autopsy 
negative sudden deaths, often attributed to sudden arrhythmic death syndrome, post mortem 
genetic testing (a.k.a molecular autopsy) is recommended [3-5]. Recent progress in the fields 
of molecular biology and human genetics have identified the genetic origin of many cardiac 
diseases [6-10], resulting in SCD and found in Sudden Infant Death Syndrome (SIDS) [4-
6,8,10-12]. SCD may be prevented if the appropriate treatment is initiated in affected 
individuals.  As many of these diseases are hereditary, establishing a post mortem diagnosis 
of a SCD victim is very important for the surviving family members. In 2007 Wedekind 
stated that postmortem genetic testing should be considered as a part of the comprehensive 
medicolegal investigation in sudden cardiac death cases without apparent structural heart 
disease, taking into consideration the implications for the living family members [13]. 
Establishing a diagnosis may prevent future cardiac events with the assistance of expert 
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counseling, appropriate lifestyle adjustment, and pharmacological treatment, if available. 
Recently, Dettmyer and Kandolf suggested that some cases of primary arrythmogenic 
disorders were misdiagnosed as SIDS [14], and Klintschar reported on the clinical 
consequences for family members resulting from a medicolegal autopsy in a case of sudden 
death due to an aortic rupture resulting from Marfan syndrome [15]. Despite the 
recommendations for and advantages of molecular autopsy, only a few research centres are 
currently performing it in standard forensic practice.  The goal of this project was to assess 
the current strategies employed by forensic practitioners. 
Methods 
The members of forensic medical associations (International Academy of Legal Medicine, 
German, Swiss and, French Societies of Legal Medicine and Mediterranean Academy of 
Forensic Sciences) were contacted by email and asked to fill out an on-line questionnaire, 
which was available during a two-week period. A total of 648 mails were sent, however the 
mailing list was not selective and included members not involved in the autopsy of SCD 
cases, such as toxicologists and psychiatrists. The questionnaire began with the presentation 
of a typical case of SCD - a 25-year-old man without any known medical history, who died 
suddenly while playing tennis. The subsequent questions concerned the respondents handling 
of the case focusing on the forensic autopsy, addressing the judges’ orders, macroscopical and 
microscopical cardiac examination, conduction tissue examination, immunohistochemistry 
and electron microscopy, biochemical markers, and the sampling and storage of material for 
genetic and toxicological analyses. Some questions concerned the legal and ethical aspects of 
genetic analyses in post-mortem testing, as well as the existence of any multidisciplinary 
collaboration. 
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Respondents 
A total of 97 surveys were completed, the majority from central and southern Europe and the 
Mediterranean. The numbers of respondents by countries are listed in Table 1. 74.7 % of the 
respondents were male, and 25.3 % were female. 
69.1% of respondents worked in a university setting, 6.2% in peripheral hospitals, 4.1% in 
private practice and 18.6% in miscellaneous places (mostly judicial administration). 70.1 % of 
respondents worked in forensic pathology, 6.2 % in forensic genetics, 4.1 % in forensic 
toxicology and the remainder in clinical forensic medicine. 58.9 % of respondents were 
involved in teaching forensic medicine. 
The professional experience of respondents was the following: 44.3% had between 1 and 10 
years of experience, 34% between 11 and 20 years, 11.3% between 21 and 30 years, and 4.1% 
greater than 30 years. 
The estimated mean number of autopsies and sudden cardiac death autopsies performed 
annually were 180 and 20, respectively. 
Autopsy ordering 
90.8 % of respondents reported that in the presented case the police officer (or investigating 
magistrate) would order a forensic autopsy.  72.2 % of respondents noted that the forensic 
autopsy did not require the consent of the next of kin, while 18.6 % said that it did. 10 % of 
6 
the respondents reported that a post-mortem investigation would not be performed for the 
presented case.  
For the respondents who said that an autopsy would not performed for the presented case, or 
would be performed in less than 50% of cases, 28.9 % noted it was mainly due to the lack of 
suspicion of third party intervention, while 11.3 % noted it was due to insufficient resources. 
Other reasons were given for 59.8 % of respondents, some of which were detailed in the free-
text comments. The differences between countries are shown in Table 2. 
Complementary exams performed in the autopsies of SCD cases 
56.7 % of forensic pathologists perform the cardiac examination alone or with the help of a 
pathologist who has a deeper knowledge of cardiovascular pathology. 34.0 % of respondents 
fix the whole heart and referee the case to an expert on cardiovascular pathology. For 9.3 % 
of respondents their practice varies depending on the pathology found, but that most 
frequently the forensic pathologist performs the initial examination and then fixes the entire 
heart before sending it to a specialised pathologist. Differences between countries are shown 
in Table 2. 
Histological examination of the myocardium using haematoxylin-eosin stain is systematically 
performed by 71.7% of respondents. This examination is never practiced, or practiced in less 
than 50 % of cases, by 18.4 % of forensic pathologists. Examination of the conduction tissue 
is systematically performed by 20.6 % of respondents, while 62.9 % of respondents never 
perform it or do so in less than 50 % of cases. 
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Immunohistochemical examination of the myocardium is systematically performed or 
performed in more than 50% of cases by 7.3 % of respondents, and never performed by 57.7 
% of respondents. 7.2 % of respondents did not know if immunohistochemical examination is 
performed or not. 
Electron microscopy of the myocardium is systematically performed or performed in more 
than 50% of cases by 5.1 % of respondents, and never performed by 86.6 % of respondents. 
5.5% of respondents did not know if electron microscopy is performed or not. 
Measurement of biomarkers (such as troponine, BNP, NT-proBNP) is practiced 
systematically or in more than 50 % of cases by only 10.3 % of respondents, never by 59.8 %, 
and in less than 50 % of cases by 23.7 %. 
Toxicological analyses are practiced systematically by 73.2 % of respondents, and never or in 
less than in 50% of cases by 13.4 % (see Table 3). 
No significant statistical differences were observed in the responses between individuals 
working in a university setting and other institutions, namely judicial centres. 
EDTA and frozen myocardium sampling 
EDTA blood is collected systematically by 49% of respondents, and never collected by 38.1 
%. The sampling of frozen myocardium, useful not only for molecular autopsy but also for 
the detection of viruses in cases suspicious for myocarditis, is systematically performed by 
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15.5 % of respondents, and never or in less than 50 % of cases by 79.4 % of respondents (see 
Table 3). 
Post-mortem genetic testing 
40.2% of respondents report having the ability to perform a molecular autopsy, while 59.8 % 
are not able to. Only a minority of respondents have the possibility to analyse the 3 genes 
currently implicated in cardiac channelopathies along with some other genes implicated in 
hypertrophic cardiomyopathy, arrhythmogenic right ventricular dysplasia/cardiomyopathy 
and polymorphic ventricular tachycardia (see Table 1).  No significant differences were 
observed between pathologists working in the university setting and other institutions. 
Legal and ethical aspect of retrospective post mortem genetic testing 
A few questions concerned the legal and ethical aspects of genetic analyses in the forensic 
context. One of the questions asked if the forensic pathologist needs the approval of the ethics 
committee and/or the consent of the next of kin in order to perform a retrospective study.  
18.6 % of respondents (2 from Germany, 2 from Portugal, 2 from Romania, 1 from Austria, 1 
from Croatia, 1 from Italy, 1 from Japan, 1 from Nigeria, 1 from Serbia, 1 from Slovakia, 4 
from Spain, and 1 from the Unites States) may perform genetic analyses in any case without 
the consent of the next of kin or the ethics committee. 25.6 % of respondents need the 
approval of the local ethics committee and the consent of the next of kin (6 from Switzerland, 
5 from Germany, 3 from France, 2 from Canada, 2 from Turkey, 1 from Iceland, 1 from 
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Spain, 2 undeclared). 26.8 % respondents need either the approval of the local ethics 
committee or that of the next of kin. 22.7 % do not have the means of performing 
retrospective genetic testing. 
Juridical authorisation to perform the molecular autopsy 
One question asked if the pathologist needs the permission of the investigating magistrate or 
prosecutor in order to perform genetic testing. 23.7 % of respondents reported that permission 
was required before performing the retrospective post-mortem screening. For juridical 
investigations, 43 out of 88 respondents do not require the permission of the investigating 
magistrate in order to perform the molecular autopsy, whereas the remaining 45 respondents 
need the authorisation in order to determine the cause of death. 
Interdisciplinary collaboration 
Collaborations between the departments of medical genetics and cardiology exist for 19.6 % 
of respondents, and more frequently (p-value <0.001) in institutions were genetic testing takes 
place (i.e. university setting). 61.9 % of respondents do not collaborate with other 
departments, which rises to 81.0 % in institutions where genetic testing is not performed. 
Approximately 20% of respondents who work in institutions that perform genetic testing do 
not have any established collaborations. 
Contact with families/ family doctors 
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One questioned asked if there was any contact established with the surviving family members 
and/or the family doctor. Such contact is more frequent in places where molecular autopsies 
are performed (p-value = 0.03, Table 4). 
Opinions about genetic testing 
58.8 % of respondents think that molecular autopsies should be performed in every case. 30.9 
% of respondents noted that testing is too expensive. When third party intervention is not 
suspected, 22.7 % of respondents think that the molecular autopsy does not have juridical 
interest, 16.5 % of respondents reported that the interpretation of the genetic results is too 
complicated, and 6.2 % answered that the “molecular autopsy is too complicated from the 
legal and ethical point of view”. Several respondents highlighted the fact that occasionally the 
forensic pathologist never receives the results of the genetic tests. Others noted that post-
mortem genetic testing was often performed “illegally”, without consent of the deceased or 
their next of kin. Many respondents suggested that the ethical issues should be more 
thoroughly discussed. 
Others comments and propositions 
A total of 29 general free-text comments were received, some of which were very detailed. 
Many comments concerned the cost of genetic testing, while others referred to the selection of 
cases and the difficulties in the interpretation of results. Respondents who require juridical 
authorisation commented on the occasional disinterest of the investigating magistrate 
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regarding the determination of the cause of death in cases without suspicion of third party 
intervention. 
Some respondents suggested that such analyses should only be performed in academic centres 
that have ethics committees and where approval of the next of kin can be obtained, and that 
these institutions should perform genetic testing for other pathologies (not just cardiac 
disease), in the hopes of preventing death in living family members. Several respondents 
noted that the tests should be covered by public heath funds at no additional cost to the 
forensic pathologist or family (e.g. Denmark) and that the samples should be preserved 
indefinitely so that relevant investigations can be performed at a later date upon the request of 
the forensic pathologist or the family doctor. Several respondents also proposed the creation 
of well-publicised national centres, funded by state money, to which all these cases should be 
referred. 
Discussion and conclusions 
According to the results of this survey, genetic testing is practiced in routine forensic 
investigations of SCD cases by only a minority of respondents. Approximately 60 % of 
respondents do not have the means to perform genetic post mortem testing and 40 % do not 
collect appropriate samples to perform these investigations, despite working in a university 
setting. There was no statistical difference in the routine practice of complementary exams, 
including molecular autopsy, between respondents who work in the university setting versus 
other institutions. The main reasons why genetic tests are so infrequently used are the 
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elevated costs of such analyses, and the legal restrictions involved with the sampling and 
storage of DNA. 
Our survey shows that routine practice varies widely with respect to the autopsy ordering, the 
standard investigations performed, and the collection and storage of samples. Molecular 
autopsies are widely used for research purposes, but in forensic practice often the most basic 
investigations are not systematically performed. Some institutions do not even perform an 
autopsy in cases of SCD, although the extent to which this occurs is very difficult to evaluate. 
When an autopsy is performed there is often no concurrent histological examination of the 
myocardium and frequently the impossibility, due to lack of availability or inexperience, to 
perform more sophisticated investigations, such as conduction tissue examination, 
immunohistochemistry, electron microscopy and biochemical marker measurement. 
Encouraging institutions to perform routine post-mortem genetic testing is inutile if even the 
basic tests are not done. The results of this survey are in accordance with a recent online 
survey of current autopsy practices performed in the United Kingdom, which showed the 
discrepancies between the guidelines published by The Royal College of Pathology and what 
is realistically achieved in daily practice. The reasons suggested by the authors are related to 
lack of time, financial constraints and the introduction of the Human Tissue Act. [16]. 
The majority of genetic heart diseases that can cause sudden cardiac death follow an 
autosomal dominant inheritance pattern, meaning that the probability of having additional 
family members affected is high. Making a diagnosis is very important as it may help prevent 
sudden deaths in living relatives [17-19]. Unfortunately, the link between the post-mortem 
forensic investigation of a sudden cardiac death victim and the clinical investigation of 
surviving family members is difficult to establish. This difficulty may result from legal 
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restrictions, such as the impossibility to obtain the consent of the next of kin, or from the 
inability to contact living family members. The respondents establish contact with the family 
in less than 30 % of cases and with the family doctor in only 16 %. Even institutions that 
routinely perform genetic testing only establish contact with the family members in 20.7 % of 
cases and with the family doctor in 13.3 %. This evokes several important ethical questions: 
What happens with the results in such cases? Do family members have access to the results? 
Another problem in the management of sudden cardiac death cases is the frequent isolation of 
the forensic pathologist from other medical fields. This may result from the historical fact that 
the forensic pathologist largely works in response to requests from magistrates or other 
judicial authorities.  They infrequently contact other specialists, except in cases where 
medical responsibility is implicated. This isolated approach is not beneficial in SCD cases, 
especially in regards to genetic testing and the transmission of results to families. 
Unfortunately, collaboration between the departments of medical genetics and cardiology 
only exists for 19.6 % of respondents. More than 80 % of the respondents who do not perform 
genetic testing declared that they do not collaborate with other departments. If more 
institutions begin to perform genetic analyses, the collaboration between services will 
hopefully increase. 
Currently, the forensic pathologist acts as an expert and does not have any clear legal 
obligations toward the family. Legal and ethical obligations do exist in other, somewhat 
similar cases [20]. The prevailing approach of forensic practitioners must be re-evaluated. 
Family members of SCD victims have increasing access to information via the Internet, and 
in their search to find an explanation for the cause of death they are sure to pose more and 
more questions. Guidelines should be established regarding autopsy procedures in cases of 
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SCD, including the responsibilities to inform living family members. These issues go beyond 
forensic medicine and require a broader discussion among health care providers. The role of 
the forensic pathologist in determining the cause of death might need to be separated from the 
public health and ethical issues of addressing the consequences for the family. 
The opinion of those experienced with genetic testing is that the best solution, currently in 
place in a few countries, is the creation of national academic centres to which all cases of 
SCD can be referred. Such centres should be well publicised, funded by central state money 
and would require the consent of the next of kin, if available. 
A limitation of this study is the low response rate of 15 %, which can partially be explained 
by the fact that the available mailing lists of members of forensic medical associations were 
non-selective and did not list their professional activities. The questionnaire was, therefore, 
sent to many individuals who are not implicated in SCD cases, i.e. forensic toxicologists, 
psychiatrists, specialists in clinical legal medicine, etc. The low response rate of forensic 
pathologists working in peripheral hospitals or in private practice may indicate that the non-
respondents of this survey are either not interested in cases of SCD or do not have the means 
to appropriately investigate them. The presented data reflects the practices and opinions of 
people who are most likely interested in the topic of SCD. Taking this into consideration, the 
percentage of institutions where a full investigation of SCD occurs is likely lower than that 
reported in this study. 
It would be very difficult to selectively contact all individuals who perform SCD autopsies 
considering the variations of forensic medical structures and practices in different countries. 
In many countries the molecular autopsies in cases of SCD are already performed by 
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professionals not trained in forensic medicine (i.e. cardiologist or cardiac pathologists) in 
order to properly inform living family members. In our opinion, the importance of the genetic 
origin of many cardiac diseases, which can result in SCD, must be emphasized, in the hopes 
of establishing multidisciplinary collaborations between forensic pathologists and other 
experts in the medical field.  
 
Conclusion 
 
This survey shows that many of the problems involved in the adequate investigation of SCD 
cases are financial in origin, and caused by the fact that activities in forensic medicine are 
paid by and often dependent on the judicial authorities. Problems also exist concerning the 
contact with the family members and/or the family doctor, as well as the often-nonexistent 
collaboration with others clinicians with special expertise, such as cardiologists and 
geneticists.  
 
It is too soon to draft final guidelines concerning molecular autopsies. As an initial step, we 
propose that each country should establish a clear legal framework for postmortem genetic 
analysis in the forensic context. In our opinion, a complete autopsy following the existing 
recommendations should be performed in all cases of SCD, and a second opinion should be 
obtained from an expert in the field of cardiovascular pathology. In the near future, the 
criteria for performing a molecular autopsy should be established in the by a team of 
international experts. The appropriate sampling and storage of material for genetic analyses is 
essential in the anticipation of future technical progress. Finally, forensic pathologists should 
realise the importance of the genetic origin of many cardiac diseases resulting in SCD and 
attempt to establish multidisciplinary collaborations.                                                  
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Tables 
Table 1 
The respondents and their ability to perform genetic post-mortem analyses in cases of SCD 
listed by country (number of respondents who answered that analysis is possible); HCM - 
hypertrophic cardiomyopathy ARDV/C- arrhythmogenic right ventricular dysplasia 
/cardiomyopathy). 
Table 2 
Reasons given by respondents for why autopsies are performed in less than 50% of cases and 
answers to the question ” In your experience, if a forensic autopsy is performed in a case of a 
sudden cardiac death, who would perform the examination of the heart?” for the total 
numbers of respondents (97) and for some countries. For statistical analysis, only 
metropolitan France was included (2 answers were from overseas regions). 
Table 3 
Complimentary exams and sampling of material for molecular autopsy. The question 
concerning the toxicological exams was:  “In cases of sudden death mentioned above, if the 
autopsy is negative, how often do you perform complete toxicological analyses (and not only 
an immunoassays screening)?” 
Table 4 
Contact with family members and/or the family doctor in cases of SCD. The responses to two 
questions (In your practice, do you have contact with family doctors of victims of SCD? In 
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your practice, do you have contact with families of victims of SCD?) were compared with the 
ability to perform the post-mortem genetic analyses in cases of SCD shown in Table1. 
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Country Numbers of 
respondents/questionnaires 
Possibility to 
perform genetic 
testing 
Analysis of 
SCN5A 
Analysis of  
KCNQ1 
Analysis of  
KCNH2 
Analysis of 
RyR2  
Analysis of 
genes 
implicated in 
HCM 
Analysis of 
genes 
implicated in 
ARDV/C 
Argentina 1/4 1 1 - - - - - 
Australia 2/2 2 - 1 1 1 1 1 
Austria 1/14 - - - - - - - 
Belgium 1/16 - - - - - - - 
Canada 2/2 1 - - - - - - 
Colombia 1/3 - - - - - - - 
Croatia 1/3 1 1 1 1 1 1 1 
Denmark 2/5 2 1 1 1 1 2 2 
France 12/156 4 2 2 2 2 3 2 
Germany 10/148 6 5 5 5 4 4 4 
Iceland 1/3 - - - - - - - 
India 3/3 1 - - - - - - 
Italy 4/24 3 1 1 1 1 2 
Japan 1/19 1 1 1 1 1 - - 
Lebanon 2/2 - - - - - - - 
Nigeria 1/1 - - - - - - - 
Portugal 4/12 - - - - - - - 
Romania 2/3 2 - - - - 1 1 
Senegal 1/2 - - - - - - - 
Serbia 1/1 1 1 1 1 1 - - 
Singapore 1/1 1 1 1 1 1 1 1 
Slovakia 1/1 - - - - - - - 
Spain 14/20 6 3 2 3 3 5 6 
Switzerland 9/119 3 3 3 3 0 2 - 
The Nederland 1/2 1 - - - - - - 
Turkey 13/13 - - - - - - - 
United Kingdom 1/4 - - - - - - - 
Unites States 2/4 1 - - - - - - 
Others countries 0/16 
Table
Table 1 
 
The respondents and their ability to perform genetic post-mortem analyses in cases of SCD listed by country (number of respondents who answered that analysis is possible); HCM - hypertrophic cardiomyopathy 
ARDV/C- arrhythmogenic right ventricular dysplasia /cardiomyopathy).  
 
All 
respondents 
Spain Turkey France Germany Switzerland Portugal Italy 
Number of answers 
(Percentage) 
97 
(100) 
14 
(100) 
13 
(100) 
10 
(100) 
10 
(100) 
9 
(100) 
4 
(100) 
4 
(100) 
Reason of a low 
autopsy rate 
Insufficient resources 11 
(11.3) 
2 
 (14.3) 
2 
(15.4) 
0 
(0) 
0 
(0) 
1 
(11.1) 
0 
(0) 
0 
(0) 
No suspicion of a third party 
intervention 
28 
(28.9) 
1 
(7.1) 
3 
(23.1) 
7 
(70.0) 
5 
(50.0) 
3 
(33.3) 
1 
(25.0) 
2 
(50.0) 
Others 58 
(59.8) 
11 
(78.6) 
8 
(61.5) 
4 
(30.0) 
5 
(50.0) 
5 
(55.6) 
2 
(50.0) 
2 
(50.0) 
Who perform 
the heart 
examination? 
Forensic pathologist 34 
(35.1) 
1 
(7.1) 
2 
(15.4) 
2 
(20.0) 
9 
(90.0) 
4 
(44.4) 
1 
(25.0) 
0 
(0) 
Forensic pathologist helped by a 
specialist 
21 
(21.6) 
2 
(14.3) 
3 
(23.1) 
1 
(10.0) 
1 
(10.0) 
4 
(44.4) 
2 
(50.0) 
3 
(75.0) 
The whole heart is fixed and 
send to a specialist 
33 
(34.0) 
10 
(71.4) 
8 
(61.5) 
4 
(40.0) 
0 
(0) 
1 
(11.1) 
1 
(25.0) 
0 
(0) 
Others 9 
(9.0) 
1 
(7.1) 
0 
(0) 
3 
(30) 
0 
(0) 
0 
(0) 
0 
(0) 
1 
(25.0) 
Table
Table 2. 
Reasons given by respondents for why autopsies are performed in less than 50% of cases and answers to the question ” In your experience, if a forensic autopsy is performed in a case of a 
sudden cardiac death, who would perform the examination of the heart?” for the total numbers of respondents (97) and for some countries. For statistical analysis, only metropolitan France was 
included (2 answers were from overseas regions).  
Number of answers 
(Percentage) 
All 
respondents 
Spain Turkey France Germany Switzerland Portugal Italy 
97 
(100) 
14 
(100) 
13 
(100) 
10 
(100) 
10 
(100) 
9 
(100) 
4 
(100) 
4 
(100) 
Performing of 
toxicological 
analyses after a 
negative autopsy 
Never 5 
(5.2) 
0 
(0) 
1 
(7.7) 
1 
(10) 
1 
(10) 
1 
(11.1) 
0 
(0) 
0 
(0) 
In less than 50 % of cases 8 
(8.3) 
0 
(0) 
0 
(0) 
1 
(10.0) 
4 
(40.0) 
0 
(0) 
0 
(0) 
0 
(0) 
In more than 50% of cases 13 
(13.4) 
2 
(14.3) 
0 
(0) 
2 
(20.0) 
2 
(20.0) 
1 
(11.1) 
1 
(25.0) 
1 
(25.0) 
In every or almost every case 71 
(73.2) 
12 
(85.7) 
12 
(92.3) 
6 
(60.0) 
3 
(30.0) 
7 
(77.8) 
3 
(75.0) 
3 
(75.0) 
Sampling of 
EDTA blood 
Never 37 
(38.1) 
5 
(35.7) 
4 
(30.8) 
4 
(40.0) 
5 
(50.0) 
1 
(11.1) 
1 
(25.0) 
0 
(0) 
In less than 50 % of cases 7 
(7.2) 
1 
(7.1) 
1 
(7.7) 
0 
(0) 
2 
(20.0) 
0 
(0) 
1 
(25.0) 
0 
(0) 
In more than 50% of cases 5 
(5.2) 
0 
(0) 
1 
(7.7) 
1 
(10.0) 
0 
(0) 
0 
(0) 
0 
(0) 
0 
(0) 
Table
In every or almost every case 48 
(49.5) 
8 
(57.1) 
7 
(53.9) 
5 
(50.0) 
3 
(30.0) 
8 
(88.9) 
2 
(50.0) 
4 
(100) 
Sampling of 
frozen 
myocardium 
Never 61 
(62.9) 
12 
(85.7) 
9 
(69.2) 
7 
(70.0) 
2 
(20.0) 
5 
(55.6) 
4 
(100) 
2 
(50.0) 
In less than 50 % of cases 16 
(16.5) 
0 
(0) 
2 
(15.4) 
0 
(0) 
6 
(60.0) 
0 
(0) 
0 
(0) 
1 
(25.0) 
In more than 50% of cases 4 
(4.1) 
1 
(7.1) 
0 
(0) 
1 
(10) 
1 
(10.0) 
0 
(0) 
0 
(0) 
0 
(0) 
In every or almost every case 15 
(15.5) 
1 
(7.1) 
2 
(15.4) 
2 
(20.0) 
1 
(10.0) 
4 
(44.4) 
0 
(0) 
1 
(25.0) 
Table 3 
Complimentary exams and sampling of material for molecular autopsy. The question concerning the toxicological exams was:  “In cases of sudden death mentioned above, if the autopsy is 
negative, how often do you perform complete toxicological analyses (and not only an immunoassays screening?”  
Frequency of 
contact 
All respondents 
(%) 
Respondents 
performing genetic 
testing (%) 
Respondents not 
performing genetic 
testing (%) 
Contact with 
families 
Never 23.7 20.7 22.8 
In less than 50 % of 
cases 
32.9 24.1 42.1 
In more than 50% of 
cases 
12.4 13.8 10.8 
Always 28.9 41.4 24.6 
Contact with family 
doctors 
Never 33.0 13.3 41.4 
In less than 50 % of 
cases 
34.0 40.0 34.5 
In more than 50% of 
cases 
16.5 16.7 13.8 
Always 16.5 30.0 10.3 
Table 4 
Contact with family members and/or the family doctor in cases of SCD. The responses to two questions (In your practice, do 
you have contact with family doctors of victims of SCD? In your practice, do you have contact with families of victims of 
SCD?) were compared with the ability to perform the post-mortem genetic analyses in cases of SCD shown in Table1.  
Table
